He aha ʻo Ivacaftor: Nā Hoʻohana, Dosage, Nā ʻaoʻao ʻaoʻao a me nā mea hou aku

He lāʻau lapaʻau ʻo Ivacaftor i hoʻolālā ʻia e mālama i ka cystic fibrosis i nā kānaka me kekahi mau loli genetic. Hana kēia lāʻau lapaʻau waha ma ke kōkua ʻana i nā protein hemahema i loko o kāu mau cell e hana maikaʻi, hiki ke hoʻomaikaʻi nui i ka hana o ka māmā a me ka maikaʻi o ke ola. He ʻāpana ia o kahi hanauna hou o nā lāʻau lapaʻau pololei e kuhikuhi ana i ke kumu kumu o ka cystic fibrosis ma mua o ka mālama ʻana i nā hōʻailona.

He aha ʻo Ivacaftor?

He lāʻau lapaʻau ʻo Ivacaftor e kuhikuhi pololei ana i ke kumu kumu o ka cystic fibrosis ma ke kelepona. ʻAʻole like me nā lāʻau lapaʻau kuʻuna e kālele ana i ka mālama ʻana i ka mucus a me nā maʻi, kōkua maoli kēia lāʻau lapaʻau i ka hoʻoponopono ʻana i nā ala protein hemahema i loko o kāu mau cell e hoʻoulu ai i ka maʻi.

No ka papa o nā mea i kapa ʻia ʻo CFTR potentiators ka lāʻau lapaʻau, ʻo ia hoʻi, hoʻonui ia i ka hana o ka protein CFTR. E noʻonoʻo iā ia e like me ke kōkua ʻana i ka wehe ʻana i nā puka i loko o kāu mau cell i paʻa, e ʻae ana i ka paʻakai a me ka wai e neʻe maʻamau ma o nā ʻiʻo o kou kino.

Hana wale ʻo Ivacaftor no nā kānaka me nā loli genetic kikoʻī o ka cystic fibrosis, ʻo ia hoʻi ka mutation G551D a me kekahi mau loli ʻē aʻe. Pono kāu kauka e hōʻoia i kāu ʻano genetic kikoʻī ma o ka hoʻāʻo ʻana ma mua o ke kau ʻana i kēia lāʻau.

No ke aha e hoʻohana ʻia ai ʻo Ivacaftor?

Hoʻohana nui ʻia ʻo Ivacaftor e mālama i ka cystic fibrosis i nā maʻi i loaʻa nā loli genetic kikoʻī e pili ana i ka hana ʻana o kā lākou protein CFTR. Ua ʻae ʻia ka lāʻau lapaʻau no nā kānaka me nā loli gating, e hōʻike ana ma kahi o 4-5% o nā maʻi cystic fibrosis a pau.

Kōkua ka lāʻau lapaʻau i ka hoʻomaikaʻi ʻana i kekahi mau mea nui o ka mālama ʻana i ka cystic fibrosis. Hiki iā ia ke hoʻomaikaʻi i ka hana o ka māmā ma ka hōʻemi ʻana i ka mucus mānoanoa a paʻa e paʻa ana i nā alaloa. Nui nā maʻi e ʻike i nā maʻi hanu liʻiliʻi a me ka hanu maikaʻi i loko o nā pule o ka hoʻomaka ʻana i ka lāʻau.

Ma waho aʻe o nā pōmaikaʻi hanu, hiki nō hoʻi i ka ivacaftor ke kōkua i nā pilikia digestive e pili ana i ka cystic fibrosis. Hiki i ka lāʻau lapaʻau ke hoʻomaikaʻi i ka hana pancreatic a hoʻemi i kekahi mau hōʻailona gastrointestinal, ʻoiai ke nānā nui ʻia nei i ke olakino o ka māmā.

Pehea e hana ai ʻo Ivacaftor?

Hana ʻo Ivacaftor ma ka hoʻopaʻa pololei ʻana i ka protein CFTR hemahema, e lilo ia i lāʻau lapaʻau ikaika me ka hana kikoʻī loa. Hana maoli ka lāʻau lapaʻau e like me ke kī e kōkua ana i ka wehe ʻana i nā kahawai protein i loko o kāu mau cell e noho paʻa ʻia ma muli o nā loli genetic.

Ke hana pono kēia mau kahawai protein, hiki i ka paʻakai a me ka wai ke neʻe maʻamau ma waena o nā membrane cell. Kōkua kēia neʻe ʻana i ka hana ʻana i ka mucus lahilahi, ʻaʻole pipili i loko o kou mau māmā a me nā ʻōkana ʻē aʻe, e maʻalahi ai ka hoʻomaʻemaʻe ʻana i nā mea huna.

Ke hoʻomau nei nā hopena o ka lāʻau lapaʻau ma mua o ka wikiwiki. ʻOiai ʻike kekahi poʻe maʻi i nā hoʻomaikaʻi ʻana i loko o kekahi mau pule, hoʻomohala maʻamau nā pōmaikaʻi piha ma luna o kekahi mau mahina o ka hoʻohana mau ʻana. Pono e lawe mau ʻia ka lāʻau lapaʻau e mālama i kāna mau hopena therapeutic.

Pehea wau e lawe ai iā Ivacaftor?

Pono e lawe ʻia ʻo Ivacaftor e like me ke kau ʻana a kāu kauka, maʻamau ʻelua i ka lā ma kahi o 12 mau hola. Hana maikaʻi ka lāʻau lapaʻau ke lawe ʻia me nā meaʻai momona, no ka mea, hoʻomaikaʻi nui kēia i ka maikaʻi o ka lawe ʻana o kou kino i ka lāʻau.

ʻO nā koho meaʻai maikaʻi e pili ana i ka waiū holoʻokoʻa, ka paʻakai, ka pata, ka pata pīkī, nā hua manu, a i ʻole nā meaʻai i kuke ʻia me ka ʻaila. E manaʻo i nā meaʻai a i ʻole nā meaʻai e loaʻa ana ma kahi o 20 grams o ka momona i ka wā e lawe ai i kēlā me kēia mahele. ʻAʻole kēia he manaʻo wale nō - ʻo ka lawe ʻana iā ivacaftor me ka ʻole o ka momona hiki ke hoʻemi i kona pono e 60%.

E hoʻāʻo e lawe i kāu mau mahele i nā manawa like i kēlā me kēia lā e mālama i nā pae paʻa i kāu ʻōnaehana. Inā pilikia ʻoe i ka hoʻomanaʻo ʻana, e hoʻonohonoho i nā puʻupuʻu kelepona a i ʻole e hoʻopili i kāu mau mahele i nā manawa ʻai maʻamau. Kōkua ka kūlike i ka hōʻoia ʻana e hana pono ka lāʻau lapaʻau.

Pehea ka lōʻihi e lawe ai au iā Ivacaftor?

He lāʻau lapaʻau lōʻihi ʻo Ivacaftor, a he mea pono ka hapanui o nā kānaka e hoʻomau mau. ʻAʻole i hoʻōla ka lāʻau lapaʻau i ka cystic fibrosis, akā kōkua ia i ka mālama ʻana i ka hana hewa ʻana o ka protein e hana ai i ka maʻi.

E nānā kāu kauka i kou holomua ma o nā hoʻokolohua hana māmā maʻamau, maʻamau i kēlā me kēia 3-6 mahina i ka wā mua. Kōkua kēia mau hoʻokolohua i ka hoʻoholo ʻana i ka maikaʻi o ka hana ʻana o ka lāʻau lapaʻau a inā pono e hoʻoponopono i ka dosage. ʻO ka hapanui o nā maʻi e pane maikaʻi ana i ka ivacaftor e hoʻomau ana i ka lawe ʻana no nā makahiki.

Pono paha kekahi poʻe e hooki no ka manawa inā loaʻa iā lākou kekahi mau hopena ʻaoʻao a i ʻole nā pilina me nā lāʻau lapaʻau ʻē aʻe. Eia naʻe, ʻo ka hooki ʻana i ka ivacaftor, ʻo ia hoʻi, e hoʻi mālie nā hōʻailona cystic fibrosis i ko lākou pae mua. Mai hooki i ka lawe ʻana i kēia lāʻau lapaʻau me ka kūkākūkā ʻole ʻana me kāu hui mālama ola.

He aha nā hopena ʻaoʻao o Ivacaftor?

Hoʻomanawanui ka hapanui o nā kānaka i ka ivacaftor, akā e like me nā lāʻau lapaʻau a pau, hiki iā ia ke hana i nā hopena ʻaoʻao mai ka maʻalahi a i ka ʻoi aku ka koʻikoʻi. ʻO ka hoʻomaopopo ʻana i ka mea e manaʻo ai hiki ke kōkua iā ʻoe e mākaukau a ʻike i ka manawa e hoʻopili ai i kāu kauka.

ʻO nā hopena ʻaoʻao maʻamau i ʻike ʻia e nā maʻi he nui, ʻo ia:

• ʻEha ke poʻo a me ka noʻonoʻo
• Nā maʻi o ka ʻōnaehana hanu luna
• ʻEha ʻōpū a i ʻole ka nausea
• ʻO ka ʻulaʻula a i ʻole nā hopena ʻili
• ʻEha ʻiʻo a i ʻole ka ʻoluʻolu hui

He maʻalahi ka maʻamau o kēia mau hopena ʻaoʻao a pinepine e hoʻomaikaʻi i ka wā e hoʻoponopono ai kou kino i ka lāʻau lapaʻau i nā pule mua o ka mālama ʻana.

ʻAʻole maʻamau akā ʻoi aku ka koʻikoʻi o nā hopena ʻaoʻao e koi i ka lāʻau lapaʻau koke. ʻO kēia mau hōʻailona e pili ana:

• ʻEha ʻōpū nui ʻaʻole e hele
• Melemele o ka ʻili a i ʻole nā maka (jaundice)
• Mimi ʻeleʻele a i ʻole nā ʻōpala māmā
• Nausea mau a i ʻole ka luaʻi
• Luhi a i ʻole nāwaliwali

Hiki i kēia mau hōʻailona ke hōʻike i nā pilikia o ke ake, he mea maʻamau ʻole ia, akā pono e loiloi koke ʻia. E nānā kāu kauka i ka hana o kou ake me nā hoʻokolohua koko maʻamau e ʻike koke i nā pilikia.

ʻO wai ka mea pono ʻole e lawe iā Ivacaftor?

ʻAʻole kūpono ʻo Ivacaftor no nā mea a pau me ka cystic fibrosis, a hiki i kekahi mau mea ke hana i kēia lāʻau lapaʻau kūpono ʻole a weliweli paha no kekahi poʻe. E loiloi pono kāu kauka i kāu moʻolelo olakino a me ke kūlana olakino i kēia manawa ma mua o ke kau ʻana.

ʻO nā kānaka e pale aku iā ivacaftor me ka poʻe me ka maʻi ate koʻikoʻi a i ʻole nā ​​enzyme ate kiʻekiʻe loa. Hoʻoponopono ʻia ka lāʻau lapaʻau e ke ake, no laila hiki i nā pilikia o ke ake ke hoʻonui me ka mālama ʻana. E nānā kāu kauka i ka hana o kou ake ma mua o ka hoʻomaka ʻana i ka lāʻau lapaʻau.

Hiki i kekahi mau lāʻau lapaʻau ke launa pū me ivacaftor, ʻo ia hoʻi kekahi mau lāʻau antibiotic, antifungals, a me nā lāʻau lapaʻau. E haʻi mau i kāu kauka e pili ana i nā lāʻau lapaʻau a pau, nā lāʻau lapaʻau ma luna o ka pāʻani, a me nā mea hoʻohui āu e lawe nei. Pono paha kekahi mau hui i nā hoʻoponopono dosage a i ʻole nā ​​lāʻau lapaʻau ʻē aʻe.

Pono nā wahine hāpai a me nā wahine e hānai ana i ka umauma e kūkākūkā pono i nā pilikia a me nā pōmaikaʻi me kā lākou hui mālama ola. ʻOiai ʻaʻole i hōʻike nā haʻawina holoholona i ka pōʻino, he palena ka ʻikepili e pili ana i ka palekana o ivacaftor i ka wā hāpai a me ka hānai ʻana i ka umauma.

Nā inoa inoa o Ivacaftor

Loaʻa pinepine ʻo Ivacaftor ma lalo o ka inoa inoa ʻo Kalydeco, i hana ʻia e Vertex Pharmaceuticals. ʻO kēia ka hoʻomākaukau mua i loaʻa i ka ʻae ʻia e ka FDA a ʻo ia ka mana i kauoha nui ʻia.

Hiki nō hoʻi iā ʻoe ke hālāwai me ivacaftor ma ke ʻano he ʻāpana o nā lāʻau lapaʻau hui e like me Orkambi (ivacaftor/lumacaftor) a i ʻole Symdeko (ivacaftor/tezacaftor). Hoʻolālā ʻia kēia mau hui no nā loli genetic like ʻole a loaʻa iā ivacaftor me nā mea hana ʻē aʻe.

ʻAʻole i loaʻa nā ʻano generic o ka ivacaftor, ʻo ia hoʻi ʻo Kalydeco a me nā huahana hui pū wale nō nā koho i kēia manawa. Hele mai ka lāʻau lapaʻau i ke ʻano papa, akā hiki ke loaʻa nā ʻano wai no nā maʻi ʻōpio.

Nā Koho ʻē aʻe o Ivacaftor

Aia nā koho lapaʻau i ka ivacaftor i kāu hoʻololi genetic kikoʻī a me ke kūlana olakino holoʻokoʻa. No nā maʻi me nā hoʻololi cystic fibrosis like ʻole, hiki i nā mea hoʻololi CFTR ʻē aʻe e like me nā hui lumacaftor/ivacaftor a i ʻole nā lāʻau lapaʻau hou e like me elexacaftor/tezacaftor/ivacaftor ke kūpono.

He mea nui nā lapaʻau cystic fibrosis kuʻuna no nā maʻi e lawe ana i ka ivacaftor. Aia kēia mau mea i nā ʻenehana hoʻomaʻemaʻe ea, nā lāʻau lapaʻau i hoʻokomo ʻia e like me dornase alfa, a me nā mea hoʻohui enzyme pancreatic. Nui nā maʻi e hoʻomau i kēia mau lāʻau lapaʻau me ka ivacaftor no ka mālama piha.

No nā maʻi ʻaʻole hiki ke lawe i ka ivacaftor a i ʻole ʻaʻole i loaʻa nā hoʻololi genetic kūpono, lilo nā lapaʻau i kālele ʻia i nā hōʻailona i ke ala mua. Hiki i kēia ke komo i nā bronchodilators, mucolytics, nā lāʻau anti-inflammatory, a me ka mālama ikaika ʻana i nā maʻi māmā.

ʻOi aku ka maikaʻi o Ivacaftor ma mua o Lumacaftor?

Hana ʻokoʻa ʻo Ivacaftor a me lumacaftor a hoʻohana pinepine ʻia pū kekahi ma mua o nā koho hoʻokūkū. He potentiator ʻo Ivacaftor e kōkua i nā protein CFTR e hana maikaʻi, ʻoiai ʻo lumacaftor he mea hoʻoponopono e kōkua i ka hoʻoneʻe ʻana i nā protein CFTR hou i ka ʻili o ke kelepona.

No nā maʻi me nā hoʻololi gating e like me G551D, maʻamau ka maikaʻi o ka ivacaftor wale nō a ʻo ia ka lāʻau lapaʻau i makemake ʻia. ʻIke pinepine kēia mau maʻi i nā hoʻomaikaʻi nui ʻana i ka hana māmā a me ke olakino holoʻokoʻa me ka ivacaftor monotherapy.

No nā maʻi me ka mutation F508del maʻamau, pono ka hui pū ʻana o lumacaftor a me ivacaftor (Orkambi). ʻAʻole lawa ka pono o kekahi lāʻau lapaʻau no kēia mau maʻi, akā hiki iā lākou ke hāʻawi i nā hoʻomaikaʻi nui i ka hana o ka māmā a me ka maikaʻi o ke ola.

Ke hilinaʻi nei ke koho ma waena o kēia mau lāʻau lapaʻau i kāu hopena hoʻokolohua genetic. E hoʻoholo kāu kauka i ke ala maikaʻi loa e pili ana i kāu mau mutation kikoʻī a me ke ʻano o ka pane ʻana o kou kino i ka lāʻau lapaʻau.

Nā Nīnau i Nīnau pinepine ʻia e pili ana iā Ivacaftor

He Palekana ʻo Ivacaftor no ka poʻe me ka maʻi diabetes?

Hiki ke hoʻohana palekana ʻia ʻo Ivacaftor i ka poʻe me ka maʻi diabetes, akā pono ia i ka nānā pono ʻana a me ka hoʻopili ʻana ma waena o kāu hui cystic fibrosis a me nā mea mālama diabetes. ʻAʻole pili pololei ka lāʻau lapaʻau i nā pae kōpaʻa koko, akā hōʻike kekahi poʻe maʻi i nā loli i kā lākou pono hoʻokele diabetes.

ʻIke kekahi poʻe me ka maʻi diabetes e pili ana i ka cystic fibrosis i ka hoʻomaikaʻi ʻana o kā lākou kaohi kōpaʻa koko ma luna o ivacaftor, ma muli paha o ka hana pancreatic maikaʻi. Eia naʻe, pono paha nā poʻe ʻē aʻe i nā hoʻoponopono i kā lākou lāʻau lapaʻau diabetes. He mea nui ka nānā mau ʻana i nā pae kōpaʻa koko ke hoʻomaka ʻoe i ka ivacaftor.

He aha kaʻu e hana ai inā ua lawe hewa au i ka nui o Ivacaftor?

Inā ua lawe hewa ʻoe i ka nui o ka ivacaftor ma mua o ka mea i kauoha ʻia, e hoʻokaʻaʻike koke i kāu kauka a i ʻole ke kikowaena mana ʻawaʻawa, ʻoiai inā maikaʻi ʻoe. ʻO ka lawe ʻana i ka nui hiki ke hoʻonui i kou pilikia o nā hopena ʻaoʻao, ʻoiai nā pilikia o ke ake a me nā pilina lāʻau.

Mai ho'āʻo e uku no ka overdose ma ka lele ʻana i kāu mahele aʻe. Akā, e hoʻi i kāu papa hana maʻamau e like me ke kuhikuhi ʻana e kāu mea mālama ola. E mālama i ka nui o ka lāʻau lapaʻau keu āu i lawe ai a me ka manawa, no ka mea, e kōkua kēia ʻike i nā poʻe loea lapaʻau e hoʻoholo i ke ala maikaʻi loa e hana ai.

He aha kaʻu e hana ai inā ua hala au i kahi mahele o Ivacaftor?

Inā e poina ʻoe i ka lāʻau ivacaftor, e lawe koke ʻoe i ka wā e hoʻomanaʻo ai ʻoe, akā inā i loko nō o 6 hola o kou manawa i hoʻonohonoho ʻia. Inā ua hala ma mua o 6 hola, e lele i ka lāʻau i poina a e lawe i kāu lāʻau aʻe i ka manawa maʻamau me ka meaʻai momona.

Mai lawe i ʻelua lāʻau i ka manawa hoʻokahi e uku ai i ka lāʻau i poina, no ka mea, hiki i kēia ke hoʻonui i kou pilikia o nā hopena ʻaoʻao. Inā poina pinepine ʻoe i nā lāʻau, e noʻonoʻo e hoʻonohonoho i nā ʻōhua kelepona a i ʻole e hoʻohana i kahi mea hoʻonohonoho pila e kōkua i ka mālama ʻana i kāu papa.

I ka manawa hea e hiki ai iaʻu ke hooki i ka lawe ʻana iā Ivacaftor?

Pono ʻoe e hooki i ka lawe ʻana iā ivacaftor ma lalo o ka mālama olakino pololei, no ka mea, ʻo ka hoʻōki ʻana i ka lāʻau lapaʻau e alakaʻi maʻamau i ka hoʻihoʻi mālie ʻana o nā hōʻailona cystic fibrosis. Pono ka hapa nui o nā maʻi e hoʻomau i ka ivacaftor no ka manawa pau ʻole e mālama i kāna mau pōmaikaʻi.

Hiki i kāu kauka ke ʻōlelo e hooki no ka manawa pōkole inā e loaʻa iā ʻoe nā hopena ʻaoʻao koʻikoʻi, pono i ke ʻoki, a i ʻole he mau pilina lāʻau koʻikoʻi. Eia naʻe, he pōkole maʻamau kēia mau hoʻomaha, a hiki i ka hapa nui o nā maʻi ke hoʻomau i ka lāʻau lapaʻau ke hoʻoponopono ʻia ka pilikia.

Hiki iaʻu ke lawe iā Ivacaftor me nā lāʻau lapaʻau cystic fibrosis ʻē aʻe?

ʻAe, hoʻohana maʻamau ʻia ʻo ivacaftor me nā lāʻau lapaʻau cystic fibrosis ʻē aʻe ma mua o ka hoʻololi ʻana iā lākou. Hoʻomau ka hapa nui o nā maʻi i kā lākou hana hoʻomaʻemaʻe ea, nā lāʻau lapaʻau i hoʻokomo ʻia, a me nā mea hoʻohui enzyme i ka wā e lawe ana iā ivacaftor.

Eia naʻe, hiki ke loaʻa kekahi mau pilina lāʻau, ʻoi aku me kekahi mau antibiotics a me antifungals i hoʻohana pinepine ʻia i ka mālama cystic fibrosis. E hōʻike mau i kāu mau mea mālama ola āpau e lawe ana ʻoe iā ivacaftor, a mai hoʻomaka i nā lāʻau lapaʻau hou me ka nānā ʻole i nā pilina mua.